Daniela Iancu Selected Research

Amelogenesis imperfecta nephrocalcinosis

2/2017

Enamel-renal syndrome in 2 patients with a mutation in FAM20 A and atypical hypertrichosis and hearing loss phenotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Iancu Research Topics

Disease

7	Stroke (Strokes) 12/2021 - 09/2014
5	Intracranial Aneurysm (Cerebral Aneurysm) 02/2022 - 04/2015
5	Aneurysm (Aneurysms) 01/2022 - 03/2014
3	Ischemic Stroke 04/2021 - 03/2016
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 12/2021 - 01/2017
2	Hemorrhage 04/2021 - 05/2014
2	Alkalosis 01/2019 - 06/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Proteinuria 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Renovascular Hypertension (Goldblatt Syndrome) 10/2020
1	Pathologic Constriction (Stenosis) 02/2019
1	Gitelman Syndrome 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Hypokalemia 01/2019
1	Hyponatremia 01/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2019
1	Blood Vessel Dissection 01/2018
1	Fanconi Syndrome (Syndrome, Fanconi) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Ruptured Aneurysm 09/2017
1	Nonsyndromic Deafness 02/2017
1	Amelogenesis imperfecta nephrocalcinosis 02/2017
1	Hypoglycemia (Reactive Hypoglycemia) 01/2017
1	SeSAME syndrome 01/2016
1	Epilepsy (Aura) 01/2016
1	Ataxia (Dyssynergia) 01/2016
1	Deafness (Deaf Mutism) 01/2016
1	Carotid-Cavernous Sinus Fistula 06/2015
1	Embolic Stroke 05/2014
1	Inflammation (Inflammations) 09/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2013
1	Crohn Disease (Crohn's Disease) 09/2013
1	Ulcerative Colitis 09/2013
1	Rett Syndrome (Rett's Disorder) 06/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2009

Drug/Important Bio-Agent (IBA)

3	Silk FDA Link 02/2019 - 06/2015
3	SaltsIBA 01/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	phosphomannomutaseIBA 12/2021 - 01/2017
2	Calcineurin InhibitorsIBA 01/2021 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 04/2016
1	NucleotidesIBA 12/2021
1	A-factor (Streptomyces)IBA 10/2020
1	Neuroprotective AgentsIBA 01/2020
1	Sodium Chloride SymportersIBA 01/2019
1	ThiazidesIBA 01/2019
1	dirhodium tetraacetate (DRTA)IBA 01/2019
1	ChloridesIBA 06/2018
1	glycine amidinotransferase (arginine-glycine amidinotransferase)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Connexin 26IBA 02/2017
1	Nonsense Codon (Nonsense Mutation)IBA 02/2017
1	Connexin 30IBA 02/2017
1	Potassium Channels (Potassium Channel)IBA 01/2016
1	Messenger RNA (mRNA)IBA 09/2013
1	Transcription Factors (Transcription Factor)IBA 09/2013
1	CytokinesIBA 09/2013
1	ChemokinesIBA 09/2013
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2013
1	Methyl-CpG-Binding Protein 2IBA 06/2012
1	Imatinib Mesylate (Gleevec)FDA Link 09/2009

Therapy/Procedure

11	Stents 02/2022 - 03/2014
6	Thrombectomy 12/2021 - 05/2014
1	Retreatment 01/2022
1	Catheters 12/2021
1	Transplantation 01/2019
1	Radiotherapy 10/2018
1	General Anesthesia 01/2018
1	Patient Discharge 09/2016
1	Therapeutics 03/2016
1	Cerebral Revascularization 05/2014
1	Ligation 09/2013